| 000 | 01557 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250513112955.0 | ||
| 264 | 0 | _c19970417 | |
| 008 | 199704s 0 0 eng d | ||
| 022 | _a0022-2623 | ||
| 024 | 7 |
_a10.1021/jm960652r _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBlackburn, B K | |
| 245 | 0 | 0 |
_aFrom peptide to non-peptide. 3. Atropisomeric GPIIbIIIa antagonists containing the 3,4-dihydro-1H-1,4-benzodiazepine-2,5-dione nucleus. _h[electronic resource] |
| 260 |
_bJournal of medicinal chemistry _cFeb 1997 |
||
| 300 |
_a717-29 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aBenzodiazepinones _xchemical synthesis |
| 650 | 0 | 4 | _aCrystallography, X-Ray |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMagnetic Resonance Spectroscopy |
| 650 | 0 | 4 | _aModels, Molecular |
| 650 | 0 | 4 | _aMolecular Conformation |
| 650 | 0 | 4 | _aMolecular Structure |
| 650 | 0 | 4 |
_aPeptides, Cyclic _xchemistry |
| 650 | 0 | 4 |
_aPlatelet Aggregation _xdrug effects |
| 650 | 0 | 4 |
_aPlatelet Aggregation Inhibitors _xchemical synthesis |
| 650 | 0 | 4 |
_aPlatelet Glycoprotein GPIIb-IIIa Complex _xantagonists & inhibitors |
| 650 | 0 | 4 | _aStereoisomerism |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 700 | 1 | _aLee, A | |
| 700 | 1 | _aBaier, M | |
| 700 | 1 | _aKohl, B | |
| 700 | 1 | _aOlivero, A G | |
| 700 | 1 | _aMatamoros, R | |
| 700 | 1 | _aRobarge, K D | |
| 700 | 1 | _aMcDowell, R S | |
| 773 | 0 |
_tJournal of medicinal chemistry _gvol. 40 _gno. 5 _gp. 717-29 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1021/jm960652r _zAvailable from publisher's website |
| 999 |
_c9045902 _d9045902 |
||